Current Advances in Breast Cancer: Implications for Developing New Treatment Strategies Through Epi-Drugs on the Road to Modifying the Epigenome
Journal of Clinical Practice and Research · 2023
DOI: 10.14744/cpr.2023.08208 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Practice and Research, 2023. Verfasst von Sercan Kenanoğlu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Erciyes University Faculty of Medicine, Kayseri, Türkiye. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Erciyes University Faculty of Medicine, Kayseri, Türkiye.
- Department of Medical Genetics, Karamanoğlu Mehmetbey University Faculty of Medicine, Karaman, Türkiye.
Zitieren
APA
Kenanoğlu, S., Yüksel, E. B., & Dündar, M. (2023). Current Advances in Breast Cancer: Implications for Developing New Treatment Strategies Through Epi-Drugs on the Road to Modifying the Epigenome. Journal of Clinical Practice and Research. https://doi.org/10.14744/cpr.2023.08208
Vancouver
Kenanoğlu S, Yüksel EB, Dündar M. Current Advances in Breast Cancer: Implications for Developing New Treatment Strategies Through Epi-Drugs on the Road to Modifying the Epigenome. Journal of Clinical Practice and Research. 2023. doi:10.14744/cpr.2023.08208
BibTeX
@article{Kenanolu2023,
author = {Kenanoğlu, Sercan and Yüksel, Emine Berrin and Dündar, Munis},
title = {Current Advances in Breast Cancer: Implications for Developing New Treatment Strategies Through Epi-Drugs on the Road to Modifying the Epigenome},
journal = {Journal of Clinical Practice and Research},
year = {2023},
doi = {10.14744/cpr.2023.08208}
}
EUVIMED